Canaccord Genuity Raises Price Target on Abaxis Inc. (ABAX); Vet Performing Well

July 27, 2012 2:42 PM EDT Send to a Friend
Get Alerts ABAX Hot Sheet
Price: $43.65 +0.28%

Rating Summary:
    3 Buy, 5 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade ABAX Now!
Canaccord Genuity reiterates a 'Hold' on Abaxis Inc. (NASDAQ: ABAX) price target of $35.00 (from $28.00).

Analyst, Jeffrey Frelick, said, "The FQ1 beat was driven by strong growth in vet and medical revenues of $32.5M (+17%) and $8.4M (+18%), respectively. Medical was boosted by its new CRO Piccolo business of $1.6M. Ex-this order, medical revenues declined 6% Y/Y...Vet revenues performing well...Ramping sales force ahead of distributor decision."

"ABAX reported a solid FQ1/13 with revs of $42M (+17%) that topped our $39M (+9%) and the Street’s $40.4M. While ABAX is demonstrating strong momentum, we maintain our HOLD on principles of valuation."

For an analyst ratings summary and ratings history on Abaxis Inc. click here. For more ratings news on Abaxis Inc. click here.

Shares of Abaxis Inc. closed at $36.87 yesterday, with a 52 week range of $19.68-$40.58.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment